%PDF-1.5
%
1 0 obj
<1 cm\) concurrent with lymphadenectomy. Seventeen patients underwent PA + PL \(PA group\), and 27 patients underwent PL alone \(PL group\). There were no significant differences in terms of overall survival \(OS; hazard ratio [HR] = 0.49; 95% CI, 0.13 to 1.82; p = 0.29\) and progression-free survival \(PFS; HR = 0.62; 95% CI, 0.19 to 2.00; p = 0.40\) between the PA group and the PL group. Both OS and PFS also failed to show significant differences, even when comparing them among 26 cases of FIGO stage I cases. Conclusions: Our data failed to show any prognostic improvement for ovarian cancer by adding para-aortic lymphadenectomy to the standard pelvic lymphadenectomy regimen. )/ModDate(D:20131224174643+08'00')/SourceModified(D:20131021084307)/Author(Hiromi Ugaki, Yosiko Komoto, Reisa Kakubari, Eriko Tanaka, Hisashi Konishi, Toshihiro Kitai, Saori Nakajima, Miho Muraji, Takayuki Enomoto, Masahiko Takemura)/CreationDate(D:20131021164311+08'00')>>
endobj
2 0 obj
<>stream
endstream
endobj
3 0 obj
<>/ProcSet[/PDF/Text]/Font<>/Properties<>>>/MediaBox[0 0 595 808]/StructParents 1/Rotate 0>>
endobj
5 0 obj
<>stream
HW]۶}_GmQ6 hh[^Iw;sHJebEc8st^cשm&hGbg,^oDou4^0h4Z,UXneo$o<嗧Pc86Rlpa"@3Md"LxkxJ-ߗ/:^Y*P8?t\|S^oxq.0^lMSЕλe&Vq KY?fY:2K*\u:ӕ-2^26PJ*E_=ß\[o"l VAJ
8ȵFcu9$q{l!Ѫdob*o-p~(r˦723/cVح|lͰK(.8vƇ2֟ʊ''F1{O- 8%wsA{fYx@u...f7^$o1fۣ(=9O1n]z|&\ً醌$ıh~e,HXsǹ䬍U;m~aC3He3=q4>vH.,?ʮеVy6d5皘l "iPga/ghةP^r+
^lANDlÿ]u x4`]ŭx56uϸ5<0TU,e@+58~A)e0bYʈN䘳UӀgA4,ѝv!"}4]/͑B<$J5orbj˒?mmӡ['2l>"c<(3xp>F"#_[?#aFeq&ugi s%Me=di~D?C湞4T@ssд[eNZTl"a~ jj/!.9+vp׆*w@FEB: ksq<02.lGUߎ$m
4㎣{ޓf
0ˎ4SդL:ި*2̆x]ZGYmS|bu7'ݶ#rLR/b
ߎx{ԩx%F;wԤTx̖E_X P(U(?#dGYՄ'A[W'@7F,LLf<*X||?. FuS_g'̆|̜RR-eLhK1G&IG'MmJ ޮ 'Tx<\-jwvDz%|UV@F:t!C5]0&-ЭܜHޛ :sq!ZVIr@jRH'KO(Ck dɞ:RQʎꇓa|b\d\HI!!+
7+.(͘